Capsugel and Bend Research Increase Spray-Dried Dispersion Capacity - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Capsugel and Bend Research Increase Spray-Dried Dispersion Capacity



Bend Research, a division of Capsugel Dosage Form Solutions (DFS), has installed its first commercial-scale spray dryer at its R&D facility in Bend, OR. The new, high-capacity pharmaceutical spray dryer can be used for scale-up, quality-by-design (QbD), and the production of appropriate toxicology study supplies.

According to the company, this can provide for quicker development activities, as well as reduced cost and more flexible use of APIs. It also allows scale-up aspects of QbD to be integrated earlier into development for spray-dried products.

The installation is part of the company's multi-stage, $20 million expansion to enhance commercial manufacturing capabilities for spray-dried dispersions at its facilities in Oregon. The expansion is expected to be complete by mid-2015.

Source: Bend Research

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here